Wallington Asset Management’s Zimmer Biomet ZBH Stock Holding History

Wallington Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-77	Closed	-$9K	–	100
2014 Q4	$9K	Hold	77	–	–	﹤0.01%	101
2014 Q3	$8K	Hold	77	–	–	﹤0.01%	99
2014 Q2	$8K	Hold	77	–	–	﹤0.01%	98
2014 Q1	$7K	Hold	77	–	–	﹤0.01%	113
2013 Q4	$7K	Hold	77	–	–	﹤0.01%	84
2013 Q3	$6K	Hold	77	–	–	﹤0.01%	86
2013 Q2	$6K	Buy	+77	New	+$5.76K	﹤0.01%	89

Other funds holding ZBH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wallington Asset Management's ZBH Position: Q1 2015 in Review

Wallington Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 77 shares — an estimated $9K sold.

Wallington Asset Management first reported a position in ZBH in Q2 2013 and held it in 7 quarters. The position peaked at $9K in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

Wallington Asset Management reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
Wallington Asset Management sold 77 Zimmer Biomet shares in Q1 2015, an estimated $9K.
Wallington Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 7 quarters.
Wallington Asset Management's Zimmer Biomet position peaked at $9K in Q4 2014.
762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Wallington Asset Management's 13F filing for Q1 2015, filed 15 Apr 2015.